Human epidermal growth factor receptor 2/3 (HER2/HER3) expression in higher-grade meningioma

被引:0
|
作者
Mair, Maximilian
Tomasich, Erwin
Paiato, Christina
Widhalm, Georg
Eckert, Franziska
Sahm, Felix
Hainfellner, Johannes A.
Berghoff, Anna Sophie
Preusser, Matthias
机构
[1] Med Univ Vienna, Dept Med 1, Div Oncol, Vienna, Austria
[2] Med Univ Vienna, Dept Neurosurg, Vienna, Austria
[3] Med Univ Vienna, Dept Radiat Oncol, Vienna, Austria
[4] Heidelberg Univ, Inst Pathol, Dept Neuropathol, Heidelberg, Germany
[5] German Canc Res Ctr, German Consortium Translat Canc Res DKTK, Clin Cooperat Unit Neuropathol, Heidelberg, Germany
[6] Med Univ Vienna, Dept Neurol, Div Neuropathol & Neurochem, Vienna, Austria
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e14063
引用
收藏
页数:1
相关论文
共 50 条
  • [11] Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
    Begnami, Maria D.
    Fukuda, Emy
    Fregnani, Jose H. T. G.
    Nonogaki, Suely
    Montagnini, Andre L.
    da Costa, Wilson L., Jr.
    Soares, Fernando A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (22) : 3030 - 3036
  • [12] The landscape of human epidermal growth factor receptor 2 (HER2) expression in gynecologic tumors (GTs)
    Duran, C. Garcia
    Musacchio, L.
    Mazzeo, R.
    Carita, L.
    Jimenez, J.
    Bejar, J. F. Grau
    Illescas, D. G.
    Fasani, R.
    Madrid, L. Farinas
    Villacampa, G.
    Oaknin, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S590 - S591
  • [13] Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity
    Hanker, Ariella B.
    Brown, Benjamin P.
    Meiler, Jens
    Marin, Arnaldo
    Jayanthan, Harikrishna S.
    Ye, Dan
    Lin, Chang-Ching
    Akamatsu, Hiroaki
    Lee, Kyung-Min
    Chatterjee, Sumanta
    Sudhan, Dhivya R.
    Servetto, Alberto
    Brewer, Monica Red
    Koch, James P.
    Sheehan, Jonathan H.
    He, Jie
    Lalani, Alshad S.
    Arteaga, Carlos L.
    CANCER CELL, 2021, 39 (08) : 1099 - +
  • [14] Human epidermal growth factor receptor 2 (HER2) and the future of bladder carcinoma
    Sarkis, Julien
    Alkassis, Marwan
    Assaf, Joy
    ARAB JOURNAL OF UROLOGY, 2020, 18 (04) : 273 - 274
  • [15] BINDING OF NEU DIFFERENTIATION FACTOR WITH THE EXTRACELLULAR DOMAIN OF HER2 AND HER3
    HORAN, T
    WEN, J
    ARAKAWA, T
    LIU, NL
    BRANKOW, D
    HU, S
    RATZKIN, B
    PHILO, JS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) : 24604 - 24608
  • [16] Human epidermal growth factor receptor 2 (HER2) in salivary gland carcinomas
    Clauditz, Till Sebastian
    Reiff, Maren
    Gravert, Linn
    Gnoss, Alexander
    Tsourlakis, Maria-Christina
    Muenscher, Adrian
    Sauter, Guido
    Bokemeyer, Carsten
    Knecht, Rainald
    Wilczak, Waldemar
    PATHOLOGY, 2011, 43 (05) : 459 - 464
  • [17] Targeting human epidermal growth factor receptor 2 (HER2) in gynecologic malignancies
    Erickson, Britt K.
    Zeybek, Burak
    Santin, Alessandro D.
    Fader, Amanda N.
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2020, 32 (01) : 57 - 64
  • [18] Dual targeting of human epidermal growth factor receptor 2 (HER2) in neoadjuvant trials for operable HER2 positive (HER2+) disease
    Jhaveri K.
    Dang C.
    Current Breast Cancer Reports, 2013, 5 (4) : 321 - 330
  • [19] A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion
    Fichter, Christiane Daniela
    Przypadlo, Camilla Maria
    Buck, Achim
    Herbener, Nicola
    Riedel, Bianca
    Schaefer, Luisa
    Nakagawa, Hiroshi
    Walch, Axel
    Reinheckel, Thomas
    Werner, Martin
    Lassmann, Silke
    JOURNAL OF PATHOLOGY, 2017, 243 (04): : 481 - 495
  • [20] ANALYSIS OF F HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 (HER2/NEU) EXPRESSION IN GASTRIC ADENOCARCINOMA
    Umar, Nadia
    Shad, Waqar
    Irfan, Maria
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (06): : 12697 - 12700